The threat of bioterrorism in the form of aerosolized smallpox is real, and policy is needed to clarify the risk of disease to the public and recommendations on vaccination.
The Declaration of Helsinki was recently revised to require that the control arm of a trial use the current standard of care, even if that standard is not generally available in developing nations where the research is being conducted.